Advisor Group Holdings, Inc. Inovio Pharmaceuticals, Inc. Transaction History

Advisor Group Holdings, Inc.

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 12, 2024	SELL	$0.35 - $0.53 $14,539 - $22,016	-41,541 Reduced 44.1%	52,663 $26,000
Q3 2023 Nov 13, 2023	SELL	$0.38 - $0.58 $98,028 - $149,622	-257,970 Reduced 73.25%	94,204 $36,000
Q2 2023 Aug 10, 2023	BUY	$0.39 - $0.94 $57,591 - $138,810	147,671 Added 72.21%	352,174 $158,000
Q1 2023 May 12, 2023	BUY	$0.79 - $1.91 $34,470 - $83,340	43,634 Added 27.12%	204,503 $167,000
Q4 2022 Feb 10, 2023	SELL	$1.41 - $2.5 $14,108 - $25,015	-10,006 Reduced 5.86%	160,869 $250,000
Q3 2022 Nov 14, 2022	SELL	$1.66 - $2.79 $14,280 - $24,002	-8,603 Reduced 4.79%	170,875 $294,000
Q2 2022 Aug 10, 2022	BUY	$1.44 - $3.98 $32,024 - $88,511	22,239 Added 14.14%	179,478 $311,000
Q1 2022 May 04, 2022	SELL	$2.97 - $5.2 $115,173 - $201,650	-38,779 Reduced 19.78%	157,239 $627,000
Q3 2021 Nov 05, 2021	BUY	$7.16 - $9.69 $293,144 - $396,727	40,942 Added 26.4%	196,018 $1.4 Million
Q2 2021 Aug 02, 2021	BUY	$6.23 - $10.03 $75,831 - $122,085	12,172 Added 8.52%	155,076 $1.44 Million
Q1 2021 May 13, 2021	SELL	$8.81 - $16.96 $31,328 - $60,309	-3,556 Reduced 2.43%	142,904 $1.33 Million
Q4 2020 Feb 10, 2021	SELL	$8.5 - $12.85 $599,615 - $906,477	-70,543 Reduced 32.51%	146,460 $1.3 Million
Q3 2020 Nov 12, 2020	BUY	$9.57 - $27.05 $785,936 - $2.22 Million	82,125 Added 60.89%	217,003 $2.59 Million
Q2 2020 Aug 14, 2020	BUY	$7.14 - $31.69 $566,023 - $2.51 Million	79,275 Added 142.57%	134,878 $3.64 Million
Q1 2020 May 18, 2020	BUY	$2.98 - $14.09 $165,696 - $783,446	55,603 New	55,603 $419,000

281K

Ticker INO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 249,400,000
Market Cap $506M
Description
Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases. Its DNA medicines platform uses precisely designed SynCon that identify and optimize the DNA se...

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

Stay updated on Advisor Group Holdings, Inc. with notifications on news.